US20020052597A1 - Transillumination catheter and system - Google Patents
Transillumination catheter and system Download PDFInfo
- Publication number
- US20020052597A1 US20020052597A1 US09/815,930 US81593001A US2002052597A1 US 20020052597 A1 US20020052597 A1 US 20020052597A1 US 81593001 A US81593001 A US 81593001A US 2002052597 A1 US2002052597 A1 US 2002052597A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- vessel
- artery
- internal
- light
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 claims abstract description 91
- 230000002093 peripheral effect Effects 0.000 claims abstract description 19
- 210000005166 vasculature Anatomy 0.000 claims abstract description 8
- 210000004351 coronary vessel Anatomy 0.000 claims description 30
- 238000001356 surgical procedure Methods 0.000 claims description 22
- 230000003872 anastomosis Effects 0.000 claims description 19
- 239000013307 optical fiber Substances 0.000 claims description 14
- 210000003462 vein Anatomy 0.000 claims description 14
- 210000001349 mammary artery Anatomy 0.000 claims description 12
- 230000002966 stenotic effect Effects 0.000 claims description 10
- 210000001367 artery Anatomy 0.000 claims description 9
- 210000003752 saphenous vein Anatomy 0.000 claims description 9
- 210000002302 brachial artery Anatomy 0.000 claims description 8
- 210000002321 radial artery Anatomy 0.000 claims description 7
- 210000001105 femoral artery Anatomy 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 4
- 210000001562 sternum Anatomy 0.000 claims description 4
- 210000001715 carotid artery Anatomy 0.000 claims description 3
- 238000004891 communication Methods 0.000 claims description 3
- 210000000709 aorta Anatomy 0.000 claims description 2
- 230000017531 blood circulation Effects 0.000 claims description 2
- 210000000038 chest Anatomy 0.000 claims description 2
- 210000002815 epigastric artery Anatomy 0.000 claims description 2
- 210000004300 gastroepiploic artery Anatomy 0.000 claims description 2
- 238000005304 joining Methods 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims 1
- 230000036770 blood supply Effects 0.000 claims 1
- 239000000463 material Substances 0.000 description 12
- 230000000747 cardiac effect Effects 0.000 description 9
- 210000003270 subclavian artery Anatomy 0.000 description 9
- 238000007675 cardiac surgery Methods 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 238000003306 harvesting Methods 0.000 description 7
- 210000000115 thoracic cavity Anatomy 0.000 description 6
- 238000005286 illumination Methods 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 210000000779 thoracic wall Anatomy 0.000 description 5
- 239000000835 fiber Substances 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- KZENBFUSKMWCJF-UHFFFAOYSA-N [5-[5-[5-(hydroxymethyl)-2-thiophenyl]-2-furanyl]-2-thiophenyl]methanol Chemical compound S1C(CO)=CC=C1C1=CC=C(C=2SC(CO)=CC=2)O1 KZENBFUSKMWCJF-UHFFFAOYSA-N 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000002594 fluoroscopy Methods 0.000 description 3
- 238000002324 minimally invasive surgery Methods 0.000 description 3
- -1 polyethylene Polymers 0.000 description 3
- 0 CCCCCCCCC(CC*(C)CCCC#**)(CCNI*)C(*)(CC)CCCCCCCCCCCCCCCCCCC* Chemical compound CCCCCCCCC(CC*(C)CCCC#**)(CCNI*)C(*)(CC)CCCCCCCCCCCCCCCCCCC* 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000005253 cladding Methods 0.000 description 2
- 210000003748 coronary sinus Anatomy 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000001839 endoscopy Methods 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 210000005003 heart tissue Anatomy 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000003601 intercostal effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000012978 minimally invasive surgical procedure Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010020843 Hyperthermia Diseases 0.000 description 1
- 206010039744 Scrotal cancer Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 230000004323 axial length Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000011846 endoscopic investigation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000002575 gastroscopy Methods 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 230000008571 general function Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000036031 hyperthermia Effects 0.000 description 1
- 210000003090 iliac artery Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002357 laparoscopic surgery Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229960001789 papaverine Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000002428 photodynamic therapy Methods 0.000 description 1
- 238000001126 phototherapy Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical compound [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000012815 thermoplastic material Substances 0.000 description 1
- 210000001042 thoracic artery Anatomy 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
- A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
- A61B5/0086—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters using infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
- A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
Abstract
A method of identifying vasculature comprising the steps of introducing an indicator in a peripheral vessel, and advancing a portion of the indicator into an internal vessel to identify said vessel. A catheter for identifying vasculature is also disclosed. The catheter is adapted to be introduced into a peripheral vessel and a portion thereof advanced into an internal vessel. The catheter comprises a light delivery portion at a distal end thereof and an expandable member located proximal to the light delivery portion.
Description
- The present invention relates generally to methods and devices for facilitating surgical procedures, and more particularly to methods and devices for transilluminating an internal blood vessel, artery or vein within a patient during a cardiac surgery procedure to facilitate locating and manipulating the vessel, artery or vein.
- Minimally invasive surgical techniques have revolutionized cardiac surgery. Minimally invasive cardiac surgery enjoys the advantages of reduced morbidity, quicker recovery times, and improved cosmesis over conventional open-chest cardiac surgery. Recent advances in endoscopic instruments and percutaneous access to a patient's thoracic cavity have made minimally invasive surgery possible. Reduction in morbidity, lower cost, and reduced trauma has made minimally invasive surgery desirable.
- However, many problems and controversies still surround the viability of minimally invasive cardiac surgical procedures. One such problem is the difficulties of locating and manipulating small vessels, arteries, or veins in a closed-chest, blind environment during, for example, a minimally invasive coronary artery bypass graft (CABG) procedure. The coronary arteries typically have a diameter in the range of between about 1 to 5 mm, and the coronary bypass graft vessels have a diameter on the order of about 1 to 4 mm for an arterial graft such as a
thoracic artery 56, or about 4 to 8 mm for a vein graft such as asaphenous vein 84. Locating and manipulating these tiny vessels is sufficiently difficult in conventional open-chest cardiac surgical procedures, and is made substantially more difficult in closed-chest, less invasive mini-thoracotomy procedures and in minimally invasive endoscopic procedures where the cardiac surgeon may not be able to view these vessels directly. Endoscopic instruments are currently used by the cardiac surgeon to view the internal thoracic cavity during a minimally invasive surgical procedure, but the use of these instruments alone has inherent drawbacks. For example, it is often difficult to differentiate the often tiny coronary arteries or coronary bypass graft vessels from other surrounding vessels and tissues with the use of endoscopic instruments alone during a minimally invasive surgical procedure. - An alternative technique for performing minimally invasive cardiac surgery procedures, therefore, is needed which facilitates locating and manipulating vessels by illumination from within the vessels. The technique should employ transillumination of a coronary vessel or coronary bypass graft vessel with light at predetermined wavelengths that are not substantially absorbed by the vessel itself, blood, other bodily fluids, or surrounding tissues and the like. The surgical technique can be applied for example, to the following areas, although it is to be understood that the present invention is by no means limited to these specific cardiac surgery procedures: (1) dissecting a left (or right) internal thoracic artery (LITA or RITA) from the chest wall in preparation for anastomosing the LITA to a native coronary vessel in a CABG procedure; (2) locating the LITA graft in a CABG repeat procedure; (3) locating the coronary artery to which a coronary bypass graft vessel is to be anastomosed; and (4) harvesting a free graft vessel, such as a saphenous vein, in preparation for anastomosing the free graft vessel to a native coronary artery in a CABG procedure. Each of these procedures will be explained in greater detail hereinafter.
- Transillumination within the body of a patient has been recognized for at least a century. As long ago as the mid-1800's, British physicians began detecting scrotal cancer by holding a lamp behind the testes and noting the shadows the tumors cast. See “Transillumination: Looking Right Through You,” Science, Vol. 261, Jul. 30, 1993 at page 560. Transillumination of the stomach was reported as early as 1911. Intraoperative transillumination of the small intestine and colon also is generally well known. See, e.g., Ambartsoumian, A., “Infrared Transillumination Gastroscopy,” Gastrointestinal Endoscopy 1995:41(3):270-71. Illuminators for transilluminating internal organs or vessels have been used in the fields of urology and gastroentology. An illuminator placed in the urethra or esophagus facilitates laproscopic and cystoscopic procedures by illuminating these organs thus avoiding unwanted damage to the organs. See, e.g., U.S. Pat. No. 5,624,432 to Angelchik (describing the preferred use of an illuminated bougie for illuminating the esophagus). Transillumination has also been used to facilitate the proper intracorporeal placement of catheters. See, e.g., U.S. Pat. No. 5,370,640 to Kolff, which discloses the use of a fiberoptic stylet device for facilitating the intracorpoeal placement of a retrograde coronary sinus catheter into the coronary sinus of a heart of a patient.
- Although illuminators are generally well known by those skilled in the art, they typically have application for diagnostic or therapeutic purposes. Examples of such devices include the illuminators disclosed in U.S. Pat. No. 5,169,395 to Narciso, Jr., U.S Pat. No. 5,196,005 to Doiron et al., U.S Pat. No. 5,269,777 to Doiron et al., U.S Pat. No. 5,330,465 to Doiron et al., U.S Pat. No. 5,441,497 to Narciso Jr., and U.S Pat. No. 5,454,794 to Narciso, Jr. et al. The devices described in those patents generally have the ability to deliver light to luminal surfaces such as blood vessels and are typically used for the diagnosis and treatment of a variety of medical conditions, with particular application to performing photodynamic therapy (PDT) in the treatment of diseased tissue such as tumors, inducing hyperthermia, or performing both percutaneous and intraoperative phototherapy of cardiovascular disease. However, despite the fact that transillumination has long been known, the present invention is believed to be the first use of transillumination to facilitate CABG surgery by any one of the methods described below.
- The present invention discloses methods and devices for identifying vasculature. The identification methods and devices described herein can be used in conjunction with a combined technique involving laparoscopy and endoscopy to facilitate viewing and manipulating internal vessels during CABG and other cardiac surgery procedures. The techniques of the present invention can be used in open-chest coronary surgery where a partial or median sternotomy is used to gain access to the heart, in closed-chest less invasive coronary surgery procedures where a mini-thoracotomy is used to gain access to the heart, or in totally endoscopic procedures where a series of small holes, or ports, in the chest wall are used to gain access to the heart.
- A method of the present invention is for identifying vasculature and generally comprises the steps of introducing an indicator in a peripheral vessel and advancing a portion of the indicator into an internal vessel to identify the vessel.
- In another aspect of the invention, a catheter for identifying vasculature is adapted to be introduced into a peripheral vessel and a portion thereof advanced into an internal vessel. The catheter generally comprises a light delivery portion at a distal end thereof, and an expandable member located proximal to the light delivery portion.
- In yet another aspect of the invention, a system for delivering energy to an internal vessel of a patient generally comprises a catheter and a catheter guide. The catheter comprises a flexible, elongated shaft having a proximal end, a distal end, and an energy transmitting diffuser located at the distal end of the shaft. The catheter guide has an opening which is sized and dimensioned to permit the catheter to be inserted longitudinally within the guide. The guide is configured for introduction into the peripheral vessel and advancement to the internal vessel to facilitate delivery of the catheter into the internal vessel.
- Additional features and advantages of the invention will be set forth in or are apparent from the detailed descriptions of the preferred embodiments found herein below.
- FIG. 1 is a schematic illustration of the transillumination catheter of the present invention.
- FIG. 2 is a longitudinal cross-sectional view of a distal end of the transillumination catheter of FIG. 1.
- FIG. 3 schematically illustrates insertion of the transillumination catheter into a brachial artery48 of a patient for advancement to a left internal
thoracic artery 56 via a leftsubclavian artery 90. - FIG. 4 is an enlarged view of a patient's heart schematically showing the transillumination catheter disposed within a subclavian artery and being advanced towards the left internal thoracic artery.
- FIG. 5 is an enlarged view of a patient's heart schematically showing the transillumination catheter disposed within a subclavian artery and being advanced towards the left internal thoracic artery in a repeat CABG procedure.
- FIG. 6 is an enlarged view of a patient's heart schematically showing the transillumination catheter disposed within a stenotic coronary artery.
- FIG. 7 schematically illustrates insertion of the transillumination catheter of FIG. 1 into a saphenous vein of a patient for illumination of the vein prior to harvesting it for a coronary anastomosis procedure, along with showing other vessels which can be illuminated.
- FIG. 8 is a schematic diagram of an alternative embodiment of the transillumination catheter of FIG. 1.
- FIG. 9 shows the transilluminator catheter device of FIG. 8 positioned within a LITA graft vessel which has an anastomotic fastener positioned about an external surface of a free end portion of the graft vessel.
- FIG. 10 shows the free end portion of the graft vessel everted over a portion of the anastomotic fastener.
- FIG. 11 shows the graft vessel with the transillumination catheter of FIG. 8 positioned therein being inserted into the target vessel through an incision in the target vessel.
- FIG. 12 is an elevated view of the anastomotic fastener following light irradiation and radial expansion of a balloon of the transillumination catheter.
- FIG. 13 is an elevated view of the anastomotic fastener after the transillumination catheter has been removed from the graft vessel showing the completed anastomosis.
- FIG. 14 is a schematic diagram of an alternative embodiment of the transillumination catheter of FIG. 1.
- FIG. 15 is a schematic illustration of a catheter guide and guide wire for facilitating placement of the transillumination catheter into an internal vessel.
- Referring now to the drawings, and first to FIG. 1, an indicator for identifying vasculature is shown and is generally indicated by the
reference numeral 10. Theindicator 10 of the present invention is useful for delivering energy, such as visible, infrared, or ultraviolet light energy, to within a vessel, artery or vein during a coronary surgery procedure, such as a CABG procedure, to illuminate the vessel, artery or vein. Such transillumination of an internal vessel facilitates locating and manipulating the vessel during the surgical procedure. Theindicator 10 can be used to facilitate open-chest coronary surgery procedures, closed-chest less invasive mini-thoracotomy surgery procedures, and totally endoscopic minimally invasive procedures. - The
indicator 10 comprises a transillumination catheter having a light delivery portion for transmitting light to identify a vessel. The light is preferably diffused over a section of the distal end of thecatheter 10 to sufficiently illuminate the vessel. Thecatheter 10 includes afiber optic connector 23 at a proximal end of the catheter which is in optical communication with an energy source (not shown), such as a laser or a broad-band light source. In the latter case, a wavelength of between about 400 and 700 nm, and more preferably between about 600 and 700 nm, is preferred since this range of wavelengths will facilitate the emitted light energy to pass through bodily tissue. Thefiber optic connector 23 can also be optically connected to an ultraviolet or infrared light energy source. Ultraviolet light typically has a wavelength of between about 100 and 400 nmn and infrared light typically has a wavelength of between about 700 and 15,000 nm. The light from the light is delivered to a single optical fiber or bundle ofoptical fibers 25 enclosed within a first,inner catheter sheath 21. The optical fiber or bundle ofoptical fibers 25 is contained within and extends the length of thecatheter 10 from thefiber optic connector 23 to the distal portion of thecatheter 10 proximal to the light diffusingend member 14 of the catheter. - The
catheter 10 includes a Y-shapedadapter 20 towards its mid-portion which is in fluid communication with an opaque,outer catheter sheath 18 which terminates at the proximal face of light diffusingend member 14.Inner catheter sheath 18 is sufficiently flexible to navigate tortuous vessels without great difficulty, and is preferably made from one or more biocompatible thermoplastic materials which have the optical and thermal properties required for this device to be operable such as Teflon®, polyurethane, polyethylene, polyethylene terephthalate, or other suitable biocompatible materials or combinations thereof. - The Y-shaped
adapter 20 includes a balloon inflation/deflation port 22 through which a fluid may be administered and fluidly communicated through an inflation/deflation channel 30 (see FIG. 2) created between theexternal sheath 18 andinner sheath 21 to theballoon 16. The distal end of thetransillumination catheter 10 includes a light diffusingend member 14 which is optically coupled to the distal face ofoptical fiber 25. The light diffusingend member 14 is marked by a pair ofradiopaque markers 13 for visualization of thecatheter 10 under x-ray fluoroscopy.Radiopaque markers 13 can be fabricated from gold, platinum, platinum-iridium, or any one of a number of other relatively dense materials. The distal portion of thecatheter 10 is curved as shown to provide steering capabilities through a vessel which obviates the need for a distal guidewire or an internal steering wire or other steering mechanism. The shape of the distal portion of the catheter can be set thermally during processing or an additional coil (not shown) can be placed into the distal portion ofcatheter 10 as is well known by a person of ordinary skill in the art. - The
transillumination catheter 10 is preferably dimensioned and configured for introduction into a peripheral vessel, such as a brachial orradial artery 51 of a patient, and advanced to an internal thoracic artery of the heart (i.e., the LITA) through a subclavian artery (i.e., the left subclavian artery 90). This will generally require a catheter length of between about 20 to 60 cm. In addition, thecatheter 10 may be configured to be inserted directly into a vein graft, such as a sapahenous vein, for illuminating the vein graft, in which case thecatheter 10 will have a similar length of between about 20 to 60 cm. Alternatively, thecatheter 10 may be adapted for introduction into afemoral artery 82 and advancement to a coronary or other vessel, such as an internal thoracic artery for example, wherein the catheter will need to be longer in length, for example about 90 to 120 cm. Thecatheter 10 may be adapted for introduction into several coronary arteries and other vessels, such as a rightcoronary artery 60, a left maincoronary artery 58, a left anterior descendingartery 64, aleft circumflex 62, anaorta 56, a proximal coronary artery, including any branches thereof, from the same or other peripheral vessels such as aradial artery 51, leftcarotid artery 52, rightcarotid artery 54, brachial artery 48,subclavian artery 90, orfemoral artery 82, in which case its length will vary depending on the particular vessel and route of administration chosen. (See FIGS. 3-7). - Referring now to FIG. 2, a longitudinal cross-sectional view of the distal end of the
transillumination catheter 10 is shown. As seen in FIG. 2, optical fiber (or bundle of optical fibers) 25 is circumferentially surrounded by cladding 27 which promotes complete internal reflection of the light transmitted down the core ofoptical fiber 25. The distal portion of thecladding 27 is surrounded by an opticalfiber centering sleeve 29. The light is transmitted from the distal face ofoptical fiber 25 to thelight diffusing medium 15 encased within light diffusingend member 14.Light diffusing medium 15 is fabricated from an optically clear substrate such as silicone with optical scattering centers distributed within the substrate. The optical scattering centers can be fabricated from alumina, silica, titanium oxide, calcium carbonate, or other suitable materials. By varying the concentration of scattering centers in thelight diffusing medium 15 from lowest at theoptical fiber 25 to greatest at therounded cap 12, as shown, either discretely or continuously, the light output distribution from the light diffusingend member 14 can be made both radially and axially uniform. Alternatively, the optical scattering centers can be uniformly distributed throughoutlight diffusing medium 15. - The
transillumination catheter 10 shown in FIGS. 1-2 can be used in any one of several novel ways to facilitate locating and manipulating vessels, arteries or veins in coronary surgery procedures. FIG. 4 shows one such novel use oftransillumination catheter 10 for locating and illuminating aLITA graft vessel 46 prior to dissecting the LITA graft from the chest wall in preparation for a CABG procedure. The LITA transillumination technique can be used in open-chest coronary surgery where a partial or median sternotomy is used to gain access to the heart or in closed-chest less invasive coronary surgery procedures where a mini-thoracotomy is used to gain access to the heart The harvest of the LITA 46 (or RITA 45) for coronary bypass grafting can also be performed thoracoscopically through three small skin incisions as fully described in Duhaylongsod, F.G. M.D., Mayfield, W.R. M.D., Wolf, R.K. M.D., “Thoracoscopic Harvest of the Internal Thoracic Artery for Coronary Bypass Grafting: A Multicenter Experience in 219 Cases,” presented at the “Facts & Myths of Minimally Invasive Cardiac Surgery: Current Trends in Thoracic Surgery IV” symposium before the 34th Annual Meeting of the Society of Thoracic Surgeons, New Orleans, LA, Jan. 24, 1998, the entire contents of which are incorporated by reference herein. The following is an exemplary usage of the LITA transillumination technique in a standard mini-thoracotomy procedure. - A transillumination catheter, such as
catheter 10 in FIGS. 1-2, is first percutaneously inserted into a peripheral vessel, such as a brachial artery 48, by conventional means and advanced with the aid of x-ray fluoroscopy into theLITA 46 via a subclavian artery to provide illumination of the LITA, as schematically illustrated in FIGS. 3-4. As noted above, thecatheter 10 can also be percutaneously inserted into other peripheral vessels as well, such as aradial artery 51 or afemoral artery 82, by a suitable technique, such as the Seldinger technique, and advanced through a subclavian artery into the LITA (or other coronary vessel). Applicants have demonstrated that the use of a transillumination catheter placed within the LITA helps to facilitate the procedure of locating, manipulating and dissecting the LITA from the chest wall without damage or unnecessary morbidity to the surrounding tissues and body structures. - After establishment of general anesthesia with a double-lumen endobronchial tube, for example, allowing complete collapse of the left or right lung, the left lung is deflated to allow access to the heart and LITA. A 6 to 8 cm left anterior thoracotomy incision is then made in the patient's chest in the fourth intercostal space. Other sites may be suitable depending on the patient's anatomy, such as the fifth or sixth intercostal space. A retractor is used to spread apart the ribs to provide access to the heart and the LITA. The LITA is then dissected under direct vision with suitable instruments introduced through the thoractomy incision, such as scissors, pliers and the like. The
balloon 16 ofcatheter 10 is used to internally seal the LITA graft vessel prior to transecting the distal end of the LITA graft in preparation for the coronary anastomosis procedure. This obviates the need for using external clamps to provide hemostasis within the graft vessel prior to transection. Following dissection of the LITA, the resulting LITA pedicle is transected with a suitable instrument such as scissors through the thoracotomy. Papaverine is then injected directly through the LITA, which is prepared for coronary anastomosis to a stenoticcoronary artery 64. The anastomosis of the LITA to the coronary artery is then performed directly through the thoracotomy incision by using conventional suturing means, or by using a novel distal anastomosis device and procedure such as described below in connection with FIGS. 8-13 and in co-pending patent application for Anastomosis Device and Method, filed on Mar. 9, 1998, and invented by Hugh Narciso, Jr. - If required, cardiac stabilization such as described in co-pending provisional patent application, Ser. No. 60/055,127, for Compositions, Apparatus and Methods for Facilitating Surgical Procedures, filed Aug. 8, 1997, and invented by Francis G. Duhaylongsod, M.D., may be used during the procedure. Other pharmacological or mechanical methods may also be used.
- A second preferred intended novel use of the present invention is for locating the LITA, for example, in a repeat coronary surgical procedure, such as in a redo CABG procedure, to prevent injury while attempting to correct an imperfect anastomosis graft between the LITA and a stenotic native coronary artery, such as the LAD. As noted above, locating the LITA during repeat CABO surgery, for example, is critical to the safety of the patient because the graft LITA represents one of the major supplies of blood to the heart. When the LITA is anastomosed to the LAD, for example, it typically is placed across the anterior surface of the heart, directly under the sternum, as shown in FIG. 5. If a second, or redo, CABG procedure needs to be performed, the cardiac surgeon typically needs to bisect the sternum to gain access to the heart. Often in doing so, the surgeon inadvertently compromises the LITA graft70 and the patient has limited alternatives if the LITA graft cannot be repaired.
- To alleviate this concern, as described above, a transillumination catheter, such as
catheter 10 in FIGS. 1-2, is percutaneously inserted into a peripheral vessel, such as a brachial artery 48 orradial artery 51, and advanced into theLITA 46 via asubclavian artery 40 to provide illumination of the LITA, as schematically illustrated in FIG. 5. We have demonstrated that light diffusing from a transillumination catheter at a specific wavelength or wavelengths (for example, at a wavelength of between about 400 and 700 nm, and more preferably between about 600 and 700 nm) which is placed within the lumen of the LITA graft vessel is completely visible through the chest wall of the patient. With a transilluminator catheter in place and theLITA graft 46 illuminated, using current techniques, a surgeon can accurately perform a partial or median sternotomy to gain access into the patient's thoracic cavity while avoiding the illuminated LITA graft vessel, thus obviating difficulties associated with acompromised LITA graft 46. A partial or median sternotomy is a procedure by which a saw or other appropriate cutting instrument is used to make a midline, longitudinal incision along a portion or the entire axial length of the patient's sternum, allowing two opposing sternal halves to be separated laterally. A large opening into the thoracic cavity is thus created, through which a surgeon may directly visualize and operate upon the heart to correct the imperfect anastomosis or diseased graft vessel. - Another preferred intended novel use for the present invention is for locating and manipulating stenotic coronary vessels to which a graft vessel is being anastomosed in a CABG procedure. When performing CABG surgery, the stenotic native coronary artery to which a graft vessel is being anastomosed is obscured by surrounding fat or cardiac tissues. The cardiac surgeon must cut through tissues to access the coronary artery for purposes of creating a clear field of view to perform the anastomosis procedure. In some instances, it is possible for the cardiac surgeon to compromise the stenotic
coronary artery 64 while attempting to cut through the fat and cardiac tissues. However, with a transilluminator catheter in place within the coronary artery, the cardiac surgeon will be able to dissect the surrounding tissues from the coronary artery thus exposing the artery for the anastomosis procedure. In this preferred use ofcatheter 10, thecatheter 10 is percutaneosuly inserted into a peripheral vessel, such as a brachial orradial artery 51, as schematically illustrated in FIG. 6. Illumination of thetransillumination catheter 10 will help the surgeon to visualize the stenoticcoronary artery 64 while the graft vessel, such as theLITA pedicle 46 shown in FIG. 6, is being anastomosed to it. - FIG. 7 schematically illustrates another preferred novel use of the
transillumination catheter 10 of the present invention for harvesting a free vessel graft, typically asaphenous vein 84, from a patient undergoing a CABG procedure. FIG. 7 illustrates the location of various vessels, including theabdominal aorta 74, the commoniliac artery 76 and thefemoral vein 80. Atransilluminator catheter 10 is percutaneously inserted under the skin and inserted into asaphenous vein 84. With the transilluminator in place and thesaphenous vein 84 illuminated, a surgeon gently dissects thesaphenous vein 84 with suitable surgical instruments, such as scissors and the like. The device may be used to transilluminate other bypass graft vessels such as agastroepiploic artery 72 or an inferiorepigastric artery 78. The use of a transillumination device placed within the vein to be harvested makes the harvesting procedure simpler and facilitates location and extraction of the graft vessel. The transillumination catheter can be used in combination with conventional endoscopic techniques to simplify the process of harvesting the vein graft in an endoscopic procedure. - FIG. 8 illustrates an alternative embodiment of the
transillumination catheter 10 of FIGS. 1-2 generally indicated byreference numeral 100, wherein like numerals represent like parts. For example, theoptical fiber 25,fiber optic connector 23,catheter sheath 21, and light diffusingend member 14 have the same general function and arrangement as described in FIGS. 1-2.Transillumination catheter 100 can be used to facilitate the coronary surgical procedures described above akin tocatheter 10, and can also be used to facilitate joining a transected graft vessel to a stenotic target vessel in a coronary anastomosis, as will be described in greater detail below. - As shown in FIG. 8, the Y-
adapter 20 ofcatheter 10 is replaced with a threearm adapter 40 which incorporates two separate and independent balloon inflation/deflation ports outer sheath 18′ to thedistal balloons 16′ and 50, respectively.Balloon 50 is affixed to theouter sheath 18′ so that theballoon 50 overlies a substantial portion of the light diffusingend member 14 ofcatheter 100. The wall of theballoon 50 is transparent at the wavelength of light being delivered to (or received from) the surrounding tissue from light diffusingend member 14. Distal and proximal toballoon 50 areradiopaque marker bands 13′ for visualization under x-ray fluoroscopy. The provision of asecond balloon 50 is advantageous where thetransillumination catheter 100 of the present invention is used in connection with a novel distal anastomosis device disclosed in co-pending patent application for “Anastomosis Device and Method,” filed on Mar. 9, 1998, and sharing a common inventor (Hugh L. Narciso, Jr.), the entire contents of which are fully incorporated by reference herein. - As described therein, an anastomotic fastener is disclosed which in one embodiment comprises a tubular sleeve formed of a deformable material, such as a light-activated polymeric material (i.e., a polycaprolactone material) which becomes formable (i.e., fluent) upon the application of light energy to the material at a specific frequency, wavelength or wavelengths. The anastomotic fastener is configured to be positioned radially adjacent a free end portion of a graft vessel, such as a LITA graft, which is then preferably everted over a portion of the tubular sleeve. The deformable material may be selectively irradiated and molded in vivo by providing an energy that produces radiation at a frequency, wavelength, or wavelengths that are readily absorbed by the material. Radial expansion of the graft vessel will permit the deformable material in its moldable state to be shaped such that the free end portion of the graft vessel in its everted configuration is in secure conforming engagement with an inner wall of the target vessel, resulting in an intima-to-intima anastomosis.
Transillumination catheter 100 can be used in lieu of the light-diffusing catheter described in the subject co-pending patent application to irradiate and radially expand the anastomotic fastener device. - For example, with reference to FIGS.9-13,
transillumination catheter 100 is first inserted into aLITA graft vessel 110 in a similar fashion as described above in connection with FIGS. 3-4, and theLITA graft vessel 110 can be illuminated and then dissected and transected usingballoon 16′ to seal the LITA prior to transecting it. With a free end portion of theLITA graft vessel 110 exposed as shown in FIG. 9 andballoon 16 expanded to occlude the vessel, a deformableanastomosis fastener device 120 can be positioned about an external surface of (or inserted into) a free end portion of theLITA graft 110, which preferably is then everted over a portion of the tubular sleeve 120 (see FIGS. 9-10). TheLITA graft vessel 110 is then inserted into atarget vessel 112, such as an LAD having astenotic region 113, through an incision in a wall of thetarget vessel 112. - With the
anastomotic fastener 120 securely positioned in thetarget vessel 112, light energy at a given wavelength or wavelengths is supplied to the light diffusingend member 14 ofcatheter 100 from the energy (not shown) viaoptical fiber 25 to irradiate, or illuminate, thetubular member 120 with light at a wavelength or wavelengths at which the deformable material readily absorbs. Upon absorption of the light energy, the deformable material formingtubular member 120 is transformed into its moldable, fluent state. Inflation of theballoon 50 causes thetubular member 120 to radially expand outwardly, thereby pressing theLITA graft vessel 110 into conforming engagement with an inner wall of target vessel 112 (see FIG. 12). If it is necessary to movecatheter 100 longitudinally within thegraft vessel 110 to, for example, precisely positionballoon 50 radially adjacenttubular member 120,balloon 16′ can be deflated slightly. This will permit longitudinal movement of thecatheter 100 within thegraft vessel 110, at whichpoint balloon 16′ can then be re-inflated fully to firmly seal thegraft vessel 110 and prevent blood flow into the anastomosis site. By discontinuing the supply of light energy from the energy, the deformable material will become non-fluent and remain in its molded configuration. Both balloons 16′, 50 are then deflated and thecatheter device 100 is withdrawn from theLITA graft vessel 110 to complete the anastomosis (see FIG. 13). - FIG. 14 is a third alternative embodiment of a transillumination catheter generally indicated by
reference numeral 200. Thetransillumination catheter 200 is similar in most respects to thetransillumination catheter 10 of FIGS. 1-2, except that the distal end of thecatheter 200 is substantially straight, and does not have a curved configuration as does the distal end ofcatheter 10. Acatheter guide 205 is shown in schematic form in FIG. 15. Theguide 205 comprises a flexible, elongatetubular body 210 which is sized and dimensioned to permitcatheter 200 to be longitudinally inserted within thetubular body 210.Tubular body 210 may be manufactured from any suitable, relatively flexible biocompatible plastic such as polyethylene, polyurethane, silicone, and the like. Theguide 205 facilitates placement oftransillumination catheter 200 within an internal vessel, such as a LITA graft vessel. Thecatheter 200 may be formed with a guide wire lumen (not shown) as described in U.S. Pat. No. 5,169,395, which is incorporated herein by reference. The lumen may be used for insertion of a guidewire or insertion of a fluoroscopic dye to assist in guiding the catheter. - In use of the above system, the
guide 205 is first percutaneously inserted into a peripheral vessel, such as a brachial artery 48,radial artery 51 orfemoral artery 82, and advanced over aguidewire 220 by conventional means to an internal vessel, such as LITA graft vessel. With the distal end oftubular body 210 positioned a short distance within the internal vessel, theguidewire 220 is pulled back and removed fromtubular body 210. Subsequently,transillumination catheter 200 can be longitudinally inserted intotubular body 210 and advanced transluminally through it such that the light transmitting diffusingend member 14′ is placed within the internal vessel and extends beyond the distal end of thetubular body 210. Alternatively,tubular body 210 may be advanced into the internal vessel to a position at which transillumination of the vessel is required. Subsequently, the distal end oftransillumination catheter 200 is advanced up to the distal end oftubular body 210, and thetubular body 210 is then pulled back a short distance over thetransillumination catheter 200 to expose the light transmittingdistal end member 14′ of thecatheter 200. Thetransillumination catheter 200 is then used to illuminate the internal vessel as described above. Theguide 205 is advantageous in that it can be used to effectively guidecatheter 200 into an internal vessel, obviating the need to shape the distal end ofcatheter 200 or to provide a guidewire or other steering mechanism withincatheter 200. - It should be understood that while the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications and equivalents may be used. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the following claims.
Claims (42)
1. A method of identifying vasculature comprising the steps of introducing an indicator in a peripheral vessel, and advancing a portion of the indicator into an internal vessel to identify said vessel.
2. The method of claim 1 wherein the step of introducing an indicator comprises introducing a catheter having a light delivery portion, and further comprising the step of activating the light delivery portion to transmit light and identify the vessel.
3. The method of claim 2 further including the step of diffusing the transmitted light.
4. The method of claim 3 wherein the light has a wavelength in the range of 100 to 1100 nm.
5. The method of claim 3 wherein the light has a wavelength in the range of 400 to 700 nm.
6. The method of claim 3 wherein the light has a wavelength in the range of 600 to 700 nm.
7. The method of claim 2 further comprising the step of occluding blood flow through the internal vessel.
8. The method of claim 7 wherein said catheter comprises a balloon and said step of occluding comprises expanding the balloon.
9. The method of claim 8 further comprising the step of transecting a distal end of said internal vessel in preparation for a coronary anastomosis after expanding the balloon.
10. The method of claim 9 wherein said internal vessel is an internal thoracic artery and further comprising the step of sealingly joining a free end of said internal thoracic artery to a stenotic coronary artery after transecting the distal end of said internal thoracic artery.
11. The method of claim 1 wherein the internal vessel comprises an internal thoracic artery.
12. The method of claim 1 wherein the internal vessel comprises a right coronary artery.
13. The method of claim 1 wherein the internal vessel comprises a left main coronary artery.
14. The method of claim 1 wherein the internal vessel comprises a left anterior descending artery.
15. The method of claim 1 wherein the internal vessel comprises a left circumflex.
16. The method of claim 1 wherein the internal vessel comprises an aorta.
17. The method of claim 1 wherein the internal vessel comprises any branches off of a proximal coronary artery.
18. The method of claim 1 wherein the internal vessel comprises a bypass graft vessel.
19. The method of claim 18 wherein the bypass graft vessel comprises a gastroepiploic artery
20. The method of claim 18 wherein the bypass graft vessel comprises an inferior epigastric artery.
21. The method of claim 1 wherein the peripheral vessel comprises a brachial artery.
22. The method of claim 1 wherein the peripheral vessel comprises a radial artery.
23. The method of claim 1 wherein the peripheral vessel comprises a femoral artery.
24. The method of claim 1 wherein the peripheral vessel comprises a carotid artery.
25. The method of claim 11 further comprising the step of dissecting at least a portion of the internal thoracic artery after advancing the indicator.
26. The method of claim 11 further comprising the step of separating a sternum after advancing the indicator.
27. A method of identifying a saphenous vein for a surgical procedure comprising the steps of introducing at least a portion of an indicator having a light delivery portion at a distal end thereof into the saphenous vein and transmitting light through the light delivery portion to identify the vein.
28. A catheter for identifying vasculature, the catheter adapted to be introduced into a peripheral vessel and a portion thereof advanced into an internal vessel, the catheter comprising a light delivery portion at a distal end thereof, and an expandable member located proximal to said light delivery portion.
29. The catheter of claim 28 further comprising an optical fiber.
30. The catheter of claim 28 wherein said light delivery portion is adapted to transmit energy having a wavelength in the range of 100 to 1100 nm.
31. The catheter of claim 28 wherein said light delivery portion is adapted to transmit energy having a wavelength in the range of 400 to 700 nm.
32. The catheter of claim 28 wherein said light delivery portion is adapted to transmit energy having a wavelength in the range of 600 to 700 nm.
33. The catheter of claim 28 further comprising a second expandable member located distal to said first expandable member and surrounding a substantial portion of said light delivery portion.
34. The catheter of claim 28 further comprising a bend in the distal end thereof to facilitate positioning the catheter in the internal vessel.
35. A method of performing a coronary artery bypass graft procedure on a patient's heart comprising the steps of:
forming at least one opening in the patient's chest;
locating a bypass graft vessel to provide an arterial blood supply;
illuminating said bypass graft vessel;
dissecting at least a portion of said bypass graft vessel;
transecting a distal end portion of said bypass graft vessel; and
connecting said distal end portion of the bypass graft vessel to a coronary artery with said bypass graft vessel in fluid communication with said coronary artery.
36. The method of claim 34 wherein said illuminating step comprises inserting a catheter having a light delivery portion into said bypass graft vessel.
37. The method of claim 35 wherein said light delivery portion is adapted to deliver light having a wavelength in the range of 100 to 1100 nm.
38. The method of claim 35 wherein said light delivery portion is adapted to deliver light having a wavelength in the range of 400 and 700 nm.
39. The method of claim 35 wherein said light delivery portion is adapted to deliver light having a wavelength in the range of 600 to 700 nm.
40. The method of claim 35 wherein said catheter comprises a balloon and further comprising the step of occluding said bypass graft vessel by inflating the balloon prior to said transecting step.
41. A system for delivering energy to an internal vessel of a patient comprising:
a catheter comprising a flexible, elongated shaft having a proximal end, a distal end, and an energy transmitting diffuser located at the distal end of the shaft; and
a catheter guide having an opening which is sized and dimensioned to permit said catheter to be inserted longitudinally within said guide, said guide being configured for introduction into the peripheral vessel and advancement to said internal vessel to facilitate delivery of said catheter into said internal vessel.
42. The system of claim 40 further comprising a guidewire adapted to extend through a longitudinal opening within the catheter guide.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/815,930 US20020052597A1 (en) | 1998-03-13 | 2001-03-22 | Transillumination catheter and system |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/042,433 US6113588A (en) | 1998-03-13 | 1998-03-13 | Transillumination catheter and method |
US35683599A | 1999-07-16 | 1999-07-16 | |
US09/815,930 US20020052597A1 (en) | 1998-03-13 | 2001-03-22 | Transillumination catheter and system |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US35683599A Continuation | 1998-03-13 | 1999-07-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020052597A1 true US20020052597A1 (en) | 2002-05-02 |
Family
ID=21921916
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/042,433 Expired - Fee Related US6113588A (en) | 1998-03-13 | 1998-03-13 | Transillumination catheter and method |
US09/814,475 Abandoned US20020038120A1 (en) | 1998-03-13 | 2001-03-21 | Method of transillumination of a coronary artery bypass graft |
US09/815,930 Abandoned US20020052597A1 (en) | 1998-03-13 | 2001-03-22 | Transillumination catheter and system |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/042,433 Expired - Fee Related US6113588A (en) | 1998-03-13 | 1998-03-13 | Transillumination catheter and method |
US09/814,475 Abandoned US20020038120A1 (en) | 1998-03-13 | 2001-03-21 | Method of transillumination of a coronary artery bypass graft |
Country Status (4)
Country | Link |
---|---|
US (3) | US6113588A (en) |
EP (1) | EP1061847A1 (en) |
AU (1) | AU2886499A (en) |
WO (1) | WO1999045837A1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060036164A1 (en) * | 2001-06-19 | 2006-02-16 | The Trustees Of The University Of Pennsylvania | Optically guided system for precise placement of a medical catheter in a patient |
US7273056B2 (en) | 2001-06-19 | 2007-09-25 | The Trustees Of The University Of Pennsylvania | Optical guidance system for invasive catheter placement |
US20070225573A1 (en) * | 2006-03-27 | 2007-09-27 | Ethicon Endo-Surgery, Inc. | Methods and devices for percutaneous illumination |
US20080039715A1 (en) * | 2004-11-04 | 2008-02-14 | Wilson David F | Three-dimensional optical guidance for catheter placement |
US20080194973A1 (en) * | 2005-09-13 | 2008-08-14 | Imam Farhad B | Light-guided transluminal catheter |
US20100179524A1 (en) * | 2009-01-09 | 2010-07-15 | Ncontact Surgical, Inc. | Method and devices for performing biatrial coagulation |
US20110015484A1 (en) * | 2009-07-16 | 2011-01-20 | Alvarez Jeffrey B | Endoscopic robotic catheter system |
US8078261B2 (en) | 2005-09-13 | 2011-12-13 | Children's Medical Center Corporation | Light-guided transluminal catheter |
US11413109B2 (en) | 2018-02-12 | 2022-08-16 | Gyrus Acmi, Inc. | Electrosurgical instrument with a functional element |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL1007349C2 (en) | 1997-10-24 | 1999-04-27 | Suyker Wilhelmus Joseph Leonardus | System for the mechanical production of anastomoses between hollow structures; as well as device and applicator for use therewith. |
US6176864B1 (en) * | 1998-03-09 | 2001-01-23 | Corvascular, Inc. | Anastomosis device and method |
US6471710B1 (en) | 1999-08-13 | 2002-10-29 | Advanced Sensor Technology, Llc | Probe position sensing system and method of employment of same |
US7101366B2 (en) * | 2000-02-15 | 2006-09-05 | Eva Corporation | Apparatus and method for performing a surgical procedure |
US6966917B1 (en) | 2000-11-09 | 2005-11-22 | Innovation Interventional Technologies B.V. | Deformable connector for mechanically connecting hollow structures |
US6558313B1 (en) | 2000-11-17 | 2003-05-06 | Embro Corporation | Vein harvesting system and method |
US6648911B1 (en) | 2000-11-20 | 2003-11-18 | Avantec Vascular Corporation | Method and device for the treatment of vulnerable tissue site |
US6629924B2 (en) * | 2000-12-15 | 2003-10-07 | Jayson D. Aydelotte | Enhanced endotracheal tube |
US7329223B1 (en) * | 2001-05-31 | 2008-02-12 | Abbott Cardiovascular Systems Inc. | Catheter with optical fiber sensor |
WO2003020103A2 (en) * | 2001-09-04 | 2003-03-13 | Amit Technology Science & Medicine Ltd. | Method of and device for therapeutic illumination of internal organs and tissues |
US7131963B1 (en) | 2002-06-27 | 2006-11-07 | Advanced Cardiovascular Systems, Inc. | Catheters and methods of using catheters |
US7493154B2 (en) * | 2002-10-23 | 2009-02-17 | Medtronic, Inc. | Methods and apparatus for locating body vessels and occlusions in body vessels |
US20040236231A1 (en) * | 2003-05-23 | 2004-11-25 | Embro Corporation | Light catheter for illuminating tissue structures |
WO2006007410A2 (en) | 2004-06-16 | 2006-01-19 | Medtronic, Inc. | Minimally invasive coring vein harvester |
US20060036274A1 (en) * | 2004-06-25 | 2006-02-16 | Usher Raymond W | One-piece vessel harvester |
US7762951B2 (en) * | 2004-06-25 | 2010-07-27 | Medtronic, Inc. | Vein harvesting system including dilator shaft and removable retractor housing |
US7515970B2 (en) | 2004-08-18 | 2009-04-07 | Cardiac Pacemakers, Inc. | Transeptal lead |
US9056192B2 (en) | 2006-01-25 | 2015-06-16 | Mayser, Llc | Stretch valve balloon catheter and methods for producing and using same |
US9586022B2 (en) | 2006-01-25 | 2017-03-07 | Mayser, Llc | Stretch valve balloon catheter and methods for producing and using same |
US9675237B2 (en) | 2005-01-26 | 2017-06-13 | Mayser, Llc | Illuminating balloon catheter and method for using the catheter |
US8382708B2 (en) | 2005-01-26 | 2013-02-26 | Mayser, Llc | Zero-pressure balloon catheter and method for using the catheter |
US9642992B2 (en) | 2005-01-26 | 2017-05-09 | Mayser, Llc | Stretch valve balloon catheter and methods for producing and using same |
US9044571B2 (en) | 2006-01-25 | 2015-06-02 | Leonard Pinchuk | Stretch valve balloon catheter and methods for producing and using same |
US9572954B2 (en) | 2005-01-26 | 2017-02-21 | Mayser, Llc | Stretch valve balloon catheter and methods for producing and using same |
US9272120B2 (en) | 2006-01-25 | 2016-03-01 | Mayser, Llc | Stretch valve balloon catheter and methods for producing and using same |
US7883503B2 (en) | 2005-01-26 | 2011-02-08 | Kalser Gary | Illuminating balloon catheter and method for using the catheter |
US8591497B2 (en) | 2006-01-25 | 2013-11-26 | Mayser, Llc | Stretch valve balloon catheter and methods for producing and using same |
US20070122344A1 (en) | 2005-09-02 | 2007-05-31 | University Of Rochester Medical Center Office Of Technology Transfer | Intraoperative determination of nerve location |
US20070167861A1 (en) * | 2005-11-29 | 2007-07-19 | Lopez George A | Cardiac output measurement devices and methods |
US9669193B2 (en) | 2006-01-25 | 2017-06-06 | Mayser, Llc | Stretch valve balloon catheter and methods for producing and using same |
US9713698B2 (en) | 2006-01-25 | 2017-07-25 | Mayser, Llc | Stretch valve balloon catheter and methods for producing and using same |
US20080161744A1 (en) | 2006-09-07 | 2008-07-03 | University Of Rochester Medical Center | Pre-And Intra-Operative Localization of Penile Sentinel Nodes |
US20080097408A1 (en) * | 2006-10-20 | 2008-04-24 | Infraredx, Inc. | Pullback Carriage Interlock System and Method for Catheter System |
EP2106531A2 (en) | 2007-01-22 | 2009-10-07 | California Institute Of Technology | Method for quantitative 3-d imaging |
AU2008244494B2 (en) | 2007-04-23 | 2010-10-21 | California Institute Of Technology | Single-lens 3-D imaging device using a polarization-coded aperture mask combined with a polarization-sensitive sensor |
US9572583B2 (en) * | 2007-11-21 | 2017-02-21 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Methods and systems for occluding vessels during cardiac ablation |
US8663321B2 (en) * | 2007-12-06 | 2014-03-04 | L. Van Thomas Crisco | Minimally invasive method for coronary bypass and other treatments |
US8514268B2 (en) | 2008-01-22 | 2013-08-20 | California Institute Of Technology | Method and device for high-resolution three-dimensional imaging which obtains camera pose using defocusing |
US8406860B2 (en) | 2008-01-25 | 2013-03-26 | Novadaq Technologies Inc. | Method for evaluating blush in myocardial tissue |
US10219742B2 (en) | 2008-04-14 | 2019-03-05 | Novadaq Technologies ULC | Locating and analyzing perforator flaps for plastic and reconstructive surgery |
ES2671710T3 (en) | 2008-05-02 | 2018-06-08 | Novadaq Technologies ULC | Methods for the production and use of erythrocytes loaded with substances for the observation and treatment of microvascular hemodynamics |
US20100191043A1 (en) * | 2009-01-27 | 2010-07-29 | Maquet Cardiovascular Llc | Methods and devices for isolating a vessel |
US10492671B2 (en) * | 2009-05-08 | 2019-12-03 | Novadaq Technologies ULC | Near infra red fluorescence imaging for visualization of blood vessels during endoscopic harvest |
US8773507B2 (en) | 2009-08-11 | 2014-07-08 | California Institute Of Technology | Defocusing feature matching system to measure camera pose with interchangeable lens cameras |
US20110301418A1 (en) * | 2010-04-20 | 2011-12-08 | Mortez Gharib | Catheter Based 3-D Defocusing Imaging |
DK3091508T3 (en) | 2010-09-03 | 2019-04-08 | California Inst Of Techn | Three-dimensional imaging system |
US11813421B2 (en) | 2010-11-10 | 2023-11-14 | Mayser, Llc | Stretch valve balloon catheter and methods for producing and using same |
US10137282B2 (en) | 2010-11-10 | 2018-11-27 | Mayser, Llc | Stretch valve balloon catheter and methods for producing and using same |
CA2914778A1 (en) | 2012-06-21 | 2013-12-27 | Novadaq Technologies Inc. | Quantification and analysis of angiography and perfusion |
US20140378792A1 (en) * | 2013-06-24 | 2014-12-25 | William S. Krimsky | Anti-fouling sleeve for indwelling catheters |
KR20160086384A (en) * | 2013-11-14 | 2016-07-19 | 가코우호우진 세이마리안나 이카다이가쿠 | Carbon monoxide poisoning resolving device, jacket for carbon monoxide poisoning treatment having said device, and catheter for carbon monoxide poisoning treatment |
CA2963987A1 (en) | 2014-09-29 | 2016-04-07 | Novadaq Technologies Inc. | Imaging a target fluorophore in a biological material in the presence of autofluorescence |
KR102012880B1 (en) | 2014-10-09 | 2019-08-22 | 노바다크 테크놀러지즈 유엘씨 | Quantification of absolute blood flow in tissue using fluorescence-mediated photoplethysmography |
WO2017132165A1 (en) | 2016-01-25 | 2017-08-03 | California Institute Of Technology | Non-invasive measurement of intraocular pressure |
US11140305B2 (en) | 2017-02-10 | 2021-10-05 | Stryker European Operations Limited | Open-field handheld fluorescence imaging systems and methods |
GR1009925B (en) * | 2019-12-13 | 2021-02-01 | Δημητριος Νικολαου Χατζης | Cutting and angleing device for intraluminal navigation |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0311295A3 (en) * | 1987-10-07 | 1990-02-28 | University College London | Improvements in surgical apparatus |
US5042980A (en) * | 1989-05-26 | 1991-08-27 | C. R. Bard, Inc. | Optical fiber diffusion tip for uniform illumination |
US5176881A (en) * | 1989-08-11 | 1993-01-05 | The University Of Tennessee Research Corporation | Fiber optic-based regenerable biosensor |
US5269777A (en) * | 1990-11-01 | 1993-12-14 | Pdt Systems, Inc. | Diffusion tip for optical fibers |
US5237638A (en) * | 1991-03-14 | 1993-08-17 | Pdt Systems | Silicone optical waveguide |
US5169395A (en) * | 1991-04-26 | 1992-12-08 | Pdt Cardiovascular, Inc. | Laser delivery system |
US6134003A (en) * | 1991-04-29 | 2000-10-17 | Massachusetts Institute Of Technology | Method and apparatus for performing optical measurements using a fiber optic imaging guidewire, catheter or endoscope |
US5624432A (en) * | 1991-10-07 | 1997-04-29 | Angelchik; Jean P. | Illuminating bougie and methods for diagnostic, therapeutic and surgical procedures |
US5196005A (en) * | 1991-11-26 | 1993-03-23 | Pdt Systems, Inc. | Continuous gradient cylindrical diffusion tip for optical fibers and method for making |
US5217456A (en) * | 1992-02-24 | 1993-06-08 | Pdt Cardiovascular, Inc. | Device and method for intra-vascular optical radial imaging |
US5237985A (en) * | 1992-06-22 | 1993-08-24 | Crystal Wind, Inc. | Uterine retractor |
US5267995A (en) * | 1992-09-01 | 1993-12-07 | Pdt Systems | Optical waveguide with flexible tip |
US5647359A (en) * | 1993-04-01 | 1997-07-15 | Terumo Kabushiki Kaisha | Measuring apparatus |
US5370640A (en) * | 1993-07-01 | 1994-12-06 | Kolff; Jack | Intracorporeal catheter placement apparatus and method |
US5588952A (en) * | 1993-08-02 | 1996-12-31 | Dandolu; Bhaktavathsala R. | Intracardiac illuminator with suction |
US5454794A (en) * | 1993-10-15 | 1995-10-03 | Pdt Systems, Inc. | Steerable light diffusing catheter |
US5441497A (en) * | 1994-07-14 | 1995-08-15 | Pdt Cardiovascular, Inc. | Light diffusing guidewire |
US5698866A (en) * | 1994-09-19 | 1997-12-16 | Pdt Systems, Inc. | Uniform illuminator for phototherapy |
US5980549A (en) * | 1995-07-13 | 1999-11-09 | Origin Medsystems, Inc. | Tissue separation cannula with dissection probe and method |
US5925054A (en) * | 1996-02-20 | 1999-07-20 | Cardiothoracic Systems, Inc. | Perfusion device for maintaining blood flow in a vessel while isolating an anastomosis |
US5722426A (en) * | 1996-02-26 | 1998-03-03 | Kolff; Jack | Coronary light probe and method of use |
-
1998
- 1998-03-13 US US09/042,433 patent/US6113588A/en not_active Expired - Fee Related
-
1999
- 1999-03-01 WO PCT/US1999/004487 patent/WO1999045837A1/en not_active Application Discontinuation
- 1999-03-01 AU AU28864/99A patent/AU2886499A/en not_active Abandoned
- 1999-03-01 EP EP99909721A patent/EP1061847A1/en not_active Withdrawn
-
2001
- 2001-03-21 US US09/814,475 patent/US20020038120A1/en not_active Abandoned
- 2001-03-22 US US09/815,930 patent/US20020052597A1/en not_active Abandoned
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7757695B2 (en) | 2001-06-19 | 2010-07-20 | The Trustees Of The University Of Pennsylvania | Method for catheter placement |
US7273056B2 (en) | 2001-06-19 | 2007-09-25 | The Trustees Of The University Of Pennsylvania | Optical guidance system for invasive catheter placement |
US7992573B2 (en) | 2001-06-19 | 2011-08-09 | The Trustees Of The University Of Pennsylvania | Optically guided system for precise placement of a medical catheter in a patient |
US20080027408A1 (en) * | 2001-06-19 | 2008-01-31 | The Trustees Of The University Of Pennsylvania | Method for catheter placement |
US20060036164A1 (en) * | 2001-06-19 | 2006-02-16 | The Trustees Of The University Of Pennsylvania | Optically guided system for precise placement of a medical catheter in a patient |
US20080039715A1 (en) * | 2004-11-04 | 2008-02-14 | Wilson David F | Three-dimensional optical guidance for catheter placement |
US20080194973A1 (en) * | 2005-09-13 | 2008-08-14 | Imam Farhad B | Light-guided transluminal catheter |
US8078261B2 (en) | 2005-09-13 | 2011-12-13 | Children's Medical Center Corporation | Light-guided transluminal catheter |
US8954134B2 (en) | 2005-09-13 | 2015-02-10 | Children's Medical Center Corporation | Light-guided transluminal catheter |
US20070225573A1 (en) * | 2006-03-27 | 2007-09-27 | Ethicon Endo-Surgery, Inc. | Methods and devices for percutaneous illumination |
US8500631B2 (en) * | 2006-03-27 | 2013-08-06 | Ethicon Endo-Surgery, Inc. | Methods and devices for percutaneous illumination |
US20100179524A1 (en) * | 2009-01-09 | 2010-07-15 | Ncontact Surgical, Inc. | Method and devices for performing biatrial coagulation |
US8241273B2 (en) | 2009-01-09 | 2012-08-14 | Ncontact Surgical, Inc. | Method and devices for coagulation of tissue |
US8465479B2 (en) | 2009-01-09 | 2013-06-18 | Ncontact Surgical, Inc. | Method and devices for performing biatrial coagulation |
US8888766B2 (en) | 2009-01-09 | 2014-11-18 | Ncontact Surgical, Inc. | Method and devices for performing biatrial coagulation |
US20100217249A1 (en) * | 2009-01-09 | 2010-08-26 | Ncontact Surgical, Inc. | Method and devices for coagulation of tissue |
US9943364B2 (en) | 2009-01-09 | 2018-04-17 | Atricure, Inc. | Method and devices for coagulation of tissue |
US9956036B2 (en) | 2009-01-09 | 2018-05-01 | Atricure, Inc. | Method and devices for coagulation of tissue |
US10722304B2 (en) | 2009-01-09 | 2020-07-28 | Atricure, Inc. | Method and devices for coagulation of tissue |
US20110015484A1 (en) * | 2009-07-16 | 2011-01-20 | Alvarez Jeffrey B | Endoscopic robotic catheter system |
US11413109B2 (en) | 2018-02-12 | 2022-08-16 | Gyrus Acmi, Inc. | Electrosurgical instrument with a functional element |
Also Published As
Publication number | Publication date |
---|---|
EP1061847A1 (en) | 2000-12-27 |
WO1999045837A1 (en) | 1999-09-16 |
US6113588A (en) | 2000-09-05 |
US20020038120A1 (en) | 2002-03-28 |
AU2886499A (en) | 1999-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6113588A (en) | Transillumination catheter and method | |
US5904147A (en) | Intravascular catheter and method of controlling hemorrhage during minimally invasive surgery | |
US5976168A (en) | Tissue separation cannula | |
US5875782A (en) | Methods and devices for minimally invasive coronary artery revascularization on a beating heart without cardiopulmonary bypass | |
US6958035B2 (en) | Medical device sheath apparatus and method of making and using same | |
US7384423B1 (en) | Tissue dissection method | |
US5873889A (en) | Tissue separation cannula with dissection probe and method | |
JP4138251B2 (en) | Direct visual subcutaneous tissue retractor | |
AU763132B2 (en) | Kit for endovascular venous surgery | |
US6685666B1 (en) | Catheters for breast surgery | |
US8961502B2 (en) | Device for irradiating an internal body surface | |
US20040236231A1 (en) | Light catheter for illuminating tissue structures | |
WO1998006450A9 (en) | Balloon catheter with visible or magnetic marker | |
US20050096501A1 (en) | Minimally invasive surgery device | |
US20080195085A1 (en) | Economical, two component, thermal energy delivery and surface cooling apparatus and its method of use | |
JPH10108827A (en) | Infrared ray system for visualizing body portion | |
US7909762B2 (en) | Vein harvesting system including dilator shaft and removable retractor housing | |
JP2000505315A (en) | Tissue separation cannula with incision probe and method | |
WO2002007632A1 (en) | Illuminating devices for medical use | |
JP2022516171A (en) | Positioning of the tube in the lumen by transillumination | |
JP7197179B2 (en) | Endoscope system and method of use | |
Katzir | Optical fibers in medicine | |
JP2018515168A (en) | Lighting guidewire with optical sensing | |
US20240099783A1 (en) | Beacon devices, systems, and methods for medical procedures | |
JP3211141B2 (en) | Body lumen identification device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |